By using network pharmacology, we identified the core components of QGSJS decoction (quercetin, kaempferol, and isorhamnetin) and the hub genes (IL6, NFKBIA, HIF1A, and VEGFA) that contribute to its anti-DKD effects. This evidence concerns the gene VEGFA and diabetic kidney disease.